Takara Bio Inc
TSE:4974
Takara Bio Inc
Revenue
Takara Bio Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Takara Bio Inc
TSE:4974
|
Revenue
¥47.7B
|
CAGR 3-Years
6%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
GNI Group Ltd
TSE:2160
|
Revenue
¥26B
|
CAGR 3-Years
39%
|
CAGR 5-Years
39%
|
CAGR 10-Years
64%
|
|
PeptiDream Inc
TSE:4587
|
Revenue
¥28.7B
|
CAGR 3-Years
35%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
Pharma Foods International Co Ltd
TSE:2929
|
Revenue
¥65.1B
|
CAGR 3-Years
30%
|
CAGR 5-Years
47%
|
CAGR 10-Years
45%
|
|
J
|
Japan Tissue Engineering Co Ltd
TSE:7774
|
Revenue
¥2.4B
|
CAGR 3-Years
3%
|
CAGR 5-Years
2%
|
CAGR 10-Years
11%
|
S
|
StemRIM Inc
TSE:4599
|
Revenue
¥2.4B
|
CAGR 3-Years
4%
|
CAGR 5-Years
64%
|
CAGR 10-Years
N/A
|
See Also
What is Takara Bio Inc's Revenue?
Revenue
47.7B
JPY
Based on the financial report for Dec 31, 2023, Takara Bio Inc's Revenue amounts to 47.7B JPY.
What is Takara Bio Inc's Revenue growth rate?
Revenue CAGR 10Y
8%
Over the last year, the Revenue growth was -42%. The average annual Revenue growth rates for Takara Bio Inc have been 6% over the past three years , 6% over the past five years , and 8% over the past ten years .